Munich, Georgia

Lothar Gremer


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lothar Gremer: Innovator in Amyloid Characterization

Introduction

Lothar Gremer is a distinguished inventor based in Munich, Germany. With a keen focus on biochemistry, he has made significant contributions to the field of peptide and protein research. His innovative approach to the quantitative characterization of amyloid and aggregated peptides has garnered attention in scientific communities.

Latest Patents

Lothar Gremer holds a patent for a groundbreaking method aimed at the quantitative characterization of amyloid and/or aggregated peptides and/or proteins in samples. This method encompasses several steps: providing a sample that includes an amyloid or aggregated peptide with specific sizes and shapes, adding an active ingredient for analysis, and separating the components based on their aggregate characteristics. Additionally, it involves the option to completely denature specific fractions into monomer building blocks and determining the concentration changes in comparison to control samples.

Career Highlights

Gremer is affiliated with Forschungszentrum Jülich GmbH, a renowned research institution in Germany. His research is pivotal in understanding amyloid-related diseases, contributing to advancements in medical science and therapeutic development. His dedication to his work is reflected in his innovative methodologies and his commitment to scientific excellence.

Collaborations

Working alongside renowned colleagues such as Luitgard Nagel-Steger and Oleksandr Brener, Lothar Gremer has fostered fruitful collaborations that have furthered the understanding of protein aggregation. Together, they explore the complexities of protein dynamics and their implications in various diseases.

Conclusion

Lothar Gremer's contributions to the field of peptide and protein characterization have established him as a notable inventor. His method for analyzing amyloid and aggregated peptides marks a significant step forward in biochemical research, showcasing the impact of innovative thinking in the pursuit of scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…